DIAGNOSING MUTATIONS W/ THERMOPHILIC DNA REPAIR ENZYMES
使用嗜热 DNA 修复酶诊断突变
基本信息
- 批准号:6016540
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-08-01 至 2000-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from the investigator's abstract) Trevigen has developed
a patented technology, the Mismatch Identification DNA Analysis System (MIDAS),
for the detection of point mutations without PCR amplification. MIDAS employs
DNA mismatch repair enzymes (MREs) to cleave an oligonucleotide probe at sites
of mismatches when hybridized to mutated target DNA. The investigators propose
to optimize MREs and increase their sensitivity for successful
commercialization. Based upon the thermodynamics of enzyme kinetics, their
approach is to search for MREs from thermophilic organisms. The investigators
have partially purified a MRE from the extreme thermophile, Thermotoga
maritima, that recognizes and cuts at all possible base mismatches, operates
at high temperatures, survives up to 20s temperature cycles from 65C to 95C,
and works well in MIDAS and in heteroduplex analysis for scanning for unknown
mutations. Specific Aims 1 and 2 of this Phase 1 SBIR address the need to
functionally purify, characterize, and, if necessary, clone this MRE. Specific
Aim 3 examines the utility of this thermophilic MRE in the detection of known
point mutations in the APC and catenin genes in human colorectal cancer cell
lines. The investigators predict that successful optimization of these MREs
will quickly translate into commercial products for the detection of known
point mutations in a variety of disease-causing genes, without the need for PCR
amplification, and for scanning for unknown mutations and single nucleotide
polymorphisms by heteroduplex analysis.
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
描述:(改编自研究者的摘要)特雷维根发展了
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jay George其他文献
Jay George的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jay George', 18)}}的其他基金
Barcoded human cells engineered with heterozygous genetic diversity to uncover toxicodynamic variability
具有杂合遗传多样性的条码人类细胞可揭示毒理学变异性
- 批准号:
10669812 - 财政年份:2021
- 资助金额:
$ 10万 - 项目类别:
Barcoded human cells engineered with heterozygous genetic diversity to uncover toxicodynamic variability
具有杂合遗传多样性的条码人类细胞可揭示毒理学变异性
- 批准号:
10634868 - 财政年份:2021
- 资助金额:
$ 10万 - 项目类别:
Immuno-CometChip for Human Skin Basal Cell Genotoxicity Testing
用于人体皮肤基底细胞遗传毒性测试的免疫彗星芯片
- 批准号:
9136447 - 财政年份:2016
- 资助金额:
$ 10万 - 项目类别:
Quantitative Real-Time DNA Repair Analysis Tools
定量实时 DNA 修复分析工具
- 批准号:
8646260 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
Discovery Tools for Chemotherapy Resistance to Cell Death.
发现化疗抵抗细胞死亡的工具。
- 批准号:
8201177 - 财政年份:2012
- 资助金额:
$ 10万 - 项目类别:
DNA repair deficient human cells for genomic variation analysis
DNA修复缺陷的人类细胞用于基因组变异分析
- 批准号:
7669435 - 财政年份:2009
- 资助金额:
$ 10万 - 项目类别:
New Sensitive Detection of Food and Water Borne Pathogens
食品和水源性病原体的新灵敏检测
- 批准号:
6990807 - 财政年份:2005
- 资助金额:
$ 10万 - 项目类别:
Development of a standard high throughput comet assay
标准高通量彗星测定的开发
- 批准号:
7287399 - 财政年份:2002
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:














{{item.name}}会员




